Analyst consensus rating
Profound Medical Analyst Rating: Strong Buy
Direct answer
Profound Medical's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $11.14.
Forecast evidence checked October 9, 2026.
Get free Profound Medical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.91
- Average price target
- $11.14
- High price target
- $12.00
- Low price target
- $10.00
- Low target gap
- +44.7%
- Target upside
- +61.2%
- High target gap
- +73.7%
- Target range width
- 28.9%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- October 9, 2026
- Valid through
- October 16, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Profound Medical?
Profound Medical has a verified Strong Buy consensus. The same dataset has an average price target of $11.14.
How far are Profound Medical's low and high targets from the recorded price?
The low target implies +44.7%, while the high target implies +73.7%.
How many analysts are included in Profound Medical's consensus?
The verified consensus includes 5 analysts.
How is Profound Medical's target upside or downside calculated?
The average target of $11.14 is divided by the recorded price of $6.91, then one is subtracted to produce +61.2%. This does not guarantee a future return.
When was Profound Medical's analyst forecast verified?
The data was verified on 2026-10-09. The dataset is valid through 2026-10-16.